194 related articles for article (PubMed ID: 25596202)
1. Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.
Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; Brown NJ; McIntyre P; Smith-Vaughan H; Skull S; Balloch A; Andrews R; Carapetis J; McDonnell J; Krause V; Morris PS
BMJ Open; 2015 Jan; 5(1):e007247. PubMed ID: 25596202
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.
Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Chatfield MD; Lehmann D; Binks M; Chang AB; Carapetis J; Krause V; Andrews R; Snelling T; Skull SA; Licciardi PV; Oguoma VM; Morris PS
Lancet Infect Dis; 2022 Sep; 22(9):1374-1387. PubMed ID: 35772449
[TBL] [Abstract][Full Text] [Related]
3. 10-Valent pneumococcal non-typeable
Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis J; Krause V; Andrews R; Snelling T; Licciardi P; Morris P; Leach AJ
BMJ Open; 2020 May; 10(5):e033511. PubMed ID: 32448790
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial.
Beissbarth J; Wilson N; Arrowsmith B; Binks MJ; Oguoma VM; Lawrence K; Llewellyn A; Mulholland EK; Santosham M; Morris PS; Smith-Vaughan HC; Cheng AC; Leach AJ
Vaccine; 2021 Apr; 39(16):2264-2273. PubMed ID: 33766422
[TBL] [Abstract][Full Text] [Related]
5. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
[TBL] [Abstract][Full Text] [Related]
6. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
[TBL] [Abstract][Full Text] [Related]
7. Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Wilson N; Arrowsmith B; Beissbarth J; Chatfield MD; Oguoma VM; Morris PS
BMC Pediatr; 2021 Mar; 21(1):117. PubMed ID: 33685411
[TBL] [Abstract][Full Text] [Related]
8. Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines.
Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Skull SA; Oguoma VM; Chatfield M; Lehmann D; Binks MJ; Licciardi PV; Andrews R; Snelling T; Krause V; Carapetis J; Chang AB; Morris PS
Int J Pediatr Otorhinolaryngol; 2023 Dec; 175():111776. PubMed ID: 37951020
[TBL] [Abstract][Full Text] [Related]
9. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.
Temple B; Toan NT; Uyen DY; Balloch A; Bright K; Cheung YB; Licciardi P; Nguyen CD; Phuong NTM; Satzke C; Smith-Vaughan H; Vu TQH; Huu TN; Mulholland EK
BMJ Open; 2018 Jun; 8(6):e019795. PubMed ID: 29884695
[TBL] [Abstract][Full Text] [Related]
11. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
12. PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.
Binks MJ; Moberley SA; Balloch A; Leach AJ; Nelson S; Hare KM; Wilson C; Morris PS; Nelson J; Chatfield MD; Tang ML; Torzillo P; Carapetis JR; Mulholland EK; Andrews RM
Vaccine; 2015 Nov; 33(48):6579-87. PubMed ID: 26529076
[TBL] [Abstract][Full Text] [Related]
13. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
Brandileone MC; Zanella RC; Almeida SCG; Brandao AP; Ribeiro AF; Carvalhanas TMP; Sato H; Andrade AL; Verani JR;
Vaccine; 2016 Nov; 34(46):5604-5611. PubMed ID: 27692770
[TBL] [Abstract][Full Text] [Related]
14. BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children.
Beissbarth J; Smith-Vaughan HC; Cheng AC; Morris PS; Leach AJ
Front Pediatr; 2022; 10():804373. PubMed ID: 35498792
[TBL] [Abstract][Full Text] [Related]
15. Density, Serotype Diversity, and Fitness of Streptococcus pneumoniae in Upper Respiratory Tract Cocolonization With Nontypeable Haemophilus influenzae.
Lewnard JA; Huppert A; Givon-Lavi N; Pettigrew MM; Regev-Yochay G; Dagan R; Weinberger DM
J Infect Dis; 2016 Nov; 214(9):1411-1420. PubMed ID: 27540112
[TBL] [Abstract][Full Text] [Related]
16. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
Nicholls TR; Leach AJ; Morris PS
Vaccine; 2016 Feb; 34(6):703-13. PubMed ID: 26742947
[TBL] [Abstract][Full Text] [Related]
17. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal
Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Wilson N; Arrowsmith B; Beissbarth J; Chatfield MD; Oguoma VM; Licciardi P; Skull S; Andrews R; Carapetis J; McDonnell J; Krause V; Morris PS
Vaccine X; 2021 Apr; 7():100086. PubMed ID: 33681756
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.
Zhang XH; Leeuwenkamp O; Oh KB; Lee YE; Kim CM
Hum Vaccin Immunother; 2018 Jan; 14(1):85-94. PubMed ID: 29115905
[TBL] [Abstract][Full Text] [Related]
20. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.
Leach AJ; Wigger C; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2014 Aug; 14():200. PubMed ID: 25109288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
